Integrative Multi-Omics Analysis for Cancer Biomarkers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 25 July 2024 | Viewed by 213
Special Issue Editors
Interests: bioinformatics; genomics; biomarker; systems biology; biomedical informatics; cancer
Special Issues, Collections and Topics in MDPI journals
Interests: maternal nutrition; environmental health; development; bioinformatics; epigenetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our previous Special Issue “Cancer Biomarkers and Bioinformatics”. Cancer biomarkers include any measurable molecular indicators of cancer risk, cancer occurrence, or patient outcome, and can be used as tools for cancer risk assessment, screening, and early detection; accurate diagnosis; patient prognosis; prediction of response to therapy; and cancer surveillance and response monitoring. They can also be developed as targeted therapies. Cancer biomarkers can be measured in tissue and liquid biopsy. Due to the development of advanced technologies such as omics and nanotechnologies, a great quantity of data related to cancer biomarkers have been generated. Bioinformatics plays a key role in correctly generating firsthand data and in leveraging secondary cancer biomarker data. Bioinformatics is involved in the biomarker discovery process, bridging the gap between initial discovery phases such as experimental design, clinical study execution, and bioanalytics, including sample preparation, separation, and high-throughput profiling, as well as data integration and the independent validation of identified candidates.
Led by Prof. Dr. Youping Deng and Dr. Kurt K. Zhang, and assisted by Dr. Yuanyuan Fu, this Special Issue welcomes all kinds of submissions which include the use of bioinformatics to process experimentally generated and/or published datasets for cancer biomarker studies.
Prof. Dr. Youping Deng
Dr. Kurt K. Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- biomedical informatics
- cancer
- genomics
- systems biology
